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Abstract. 
 
The 
 
Tight skin
 
 (
 
Tsk
 
) mutation is a duplica-
tion of the mouse ﬁbrillin 1 (
 
Fbn1
 
) gene that results in a 
 
larger (418 kD) than normal (350 kD) protein; 
 
Tsk
 
/
 
1
 
 
mice display increased connective tissue, bone over-
growth, and lung emphysema. Lung emphysema, bone 
overgrowth, and vascular complications are the distinc-
tive traits of mice with reduced 
 
Fbn1
 
 gene expression 
and of Marfan syndrome (MFS) patients with heterozy-
gous ﬁbrillin 1 mutations. Although 
 
Tsk
 
/
 
1
 
 mice pro-
duce equal amounts of the 418- and 350-kD proteins, 
they exhibit a relatively mild phenotype without the 
vascular complications that are associated with MFS 
patients and ﬁbrillin 1–deﬁcient mice. We have used ge-
netic crosses, cell culture assays and Tsk-speciﬁc anti-
bodies to reconcile this discrepancy and gain new in-
sights into microﬁbril assembly. Mice compound 
heterozygous for the 
 
Tsk
 
 mutation and hypomorphic 
 
Fbn1
 
 alleles displayed both 
 
Tsk
 
 and MFS traits. Analy-
ses of immunoreactive ﬁbrillin 1 microﬁbrils using 
 
Tsk
 
- 
and species-speciﬁc antibodies revealed that the mutant 
cell cultures elaborate a less abundant and morphologi-
cally different meshwork than control cells. Cocultures 
of 
 
Tsk
 
/
 
Tsk
 
 ﬁbroblasts and human WISH cells that do 
not assemble ﬁbrillin 1 microﬁbrils, demonstrated that 
Tsk ﬁbrillin 1 copolymerizes with wild-type ﬁbrillin 1. 
Additionally, copolymerization of Tsk ﬁbrillin 1 with 
wild-type ﬁbrillin 1 rescues the abnormal morphology 
of the 
 
Tsk
 
/
 
Tsk
 
 aggregates. Therefore, the studies sug-
gest that bone and lung abnormalities of 
 
Tsk
 
/
 
1
 
 mice 
are due to copolymerization of mutant and wild-type 
molecules into functionally deﬁcient microﬁbrils. How-
ever, vascular complications are not present in these 
animals because the level of functional microﬁbrils 
does not drop below the critical threshold. Indirect in 
vitro evidence suggests that a potential mechanism for 
the dominant negative effects of incorporating Tsk 
ﬁbrillin 1 into microﬁbrils is increased proteolytic sus-
ceptibility conferred by the duplicated 
 
Tsk
 
 region.
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Introduction
 
Morphologically distinct networks of elastic fibers are
present in the extracellular matrix of virtually every organ
and are particularly abundant in tissues subjected to peri-
odic stress, such as the respiratory and cardiovascular sys-
tems (Mecham and Davies, 1994; Ramirez, 1996). All elas-
tic fibers are similarly composed of an amorphous core of
cross-linked elastin embedded within a peripheral mantle
of microfibrils. Microfibrillar aggregates devoid of elastin
are also widely distributed in the connective tissue, where
they are believed to connect elastic fibers, anchor cells to
the matrix, hold organ structures in place, confer tensile
strength, and provide structural support (Mecham and
Davies, 1994; Ramirez, 1996). Microfibrils are thought to
regulate the assembly and organization of the elastic fibers
by providing the scaffold that guides tropoelastin deposi-
tion during organogenesis (Mecham and Davies, 1994).
Electron microscopy has resolved the microfibrils into ag-
gregates of threadlike filaments composed of periodically
spaced globular domains (beads) connected by multiple
linear arms (Keene et al., 1991; Ren et al., 1991). Addi-
tional analyses have demonstrated that the filaments of
the beaded structure correspond to parallel fibrillin mono-
mers aligned in a head-to-tail configuration, but have left
unresolved the biochemical nature of the intervening
beads (Sakai et al., 1991; Reinhardt et al., 1996). In spite of
much effort, the molecular mechanisms driving fibrillin
polymerization and microfibril assembly are largely un-
known. The process can be broadly summarized as consist-
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ing of the following two steps: (1) polymerization of fibril-
lin 1 monomers into microfibrils; and (2) aggregation of
fibrillin 1 microfibrils into microfibrillar bundles (see Fig. 1
a). Naturally occurring and artificially generated mutations in
humans and mice have shed some light on the contributions
of the fibrillins to the formation and function of microfibrillar
aggregates (Ramirez, 1996; Pereira et al., 1997, 1999).
Fibrillins 1 and 2 display superimposable multidomain
structures that consist mainly of calcium-binding epidermal
growth factor-like (cbEGF)
 
1
 
 repeats interspersed by a novel
cysteine-rich (8-cys) motif, present only in the fibrillins
and latent transforming growth factor-
 
b
 
–binding proteins
(Ramirez, 1996). Heterozygous mutations of fibrillin 1 give
rise to the pleiotropic manifestations of Marfan syndrome
(MFS), which principally involve the musculoskeletal, ocu-
lar, and cardiovascular systems (Dietz et al., 1994). A dis-
secting aneurysm with subsequent rupture of the aortic wall
is the main cardiovascular symptom of MFS and the leading
cause of premature death of affected individuals. The initial
model of MFS pathogenesis postulated that mutant fibrillin
1 molecules exert a dominant negative activity on elastic fi-
ber formation by interfering with microfibrillar assembly
and/or function (Dietz et al., 1994; Ramirez, 1996; see Fig. 1
b). Herein, the term “antimorph” will be used to describe
the dominant negative activity of structurally defective
fibrillin 1 molecules on the wild-type counterparts.
Two lines of mutant fibrillin 1 mice that were created by
homologous gene targeting have recently refined and ex-
tended this pathogenic model (Pereira et al., 1997, 1999).
The first line of mice (mg
 
D
 
) contains a mutation that com-
bines a structural defect of fibrillin 1 with reduced gene ex-
pression. As a result, the mg
 
D
 
 allele produces 5–10% of
the normal amount of fibrillin 1 with an internal deletion
of 272 amino acids (Pereira et al., 1997). Heterozygous
mutant mice are asymptomatic and morphologically nor-
mal because the 10-fold excess of wild-type protein over-
rides the negative effect of the antimorphic mg
 
D
 
 product.
 
On the other hand, homozygous mg
 
D
 
 animals die of MFS-
like vascular complications within the first month of post-
natal life as a result of substantial fibrillin 1 deficiency. The
second line of mice (mgR) contains a mutation that pro-
duces 15–20% the amount of wild-type fibrillin 1 (Pereira
et al., 1999). Whereas mgR/
 
1
 
 mice are normal, mgR/mgR
animals produce less than optimal amount of fibrillin 1 mi-
crofibrils, gradually develop skeletal abnormalities, and
eventually die during early adulthood (4–8 mo) of respira-
tory distress and MFS-like vascular complications. Herein,
the term “hypomorph” will be used to describe fibrillin 1
mutations with weaker expression than the wild-type gene.
Taken together, the human and mouse studies indicate
that antimorphic mutations (i.e., structural defects) and
hypomorphic mutations (i.e., reduced expression) of fibril-
lin 1 equally lead to a pleiotropic phenotype that includes
the biomechanical failure of the aortic wall (see Fig. 1 a).
These studies also suggest a threshold effect, whereby the
relative abundance of functionally competent microfibrils
determines the incremental appearance and degree of se-
verity of distinct MFS traits (Pereira et al., 1999). How-
ever, this model is inconsistent with the recent character-
ization of fibrillin 1 mutation in the 
 
Tight skin
 
 (
 
Tsk
 
) mouse
(Green et al., 1975; Siracusa et al., 1996).
The 
 
Tsk
 
 mutation is a genomic duplication within the
mouse fibrillin 1 (
 
Fbn1
 
) gene that results in the production
of normal levels of a mutant protein with 984 additional
amino acids and a predicted molecular mass of 418 kD
(Fig. 2; Siracusa et al., 1996). The duplication includes the
region deleted in the mg
 
D
 
 allele. According to the domi-
nant negative model of MFS mutations, the 
 
Tsk
 
 gene
product should negatively affect the function of the wild-
type molecules and its antimorphic effect should cause
vascular complications and the premature death of 
 
Tsk
 
/
 
1
 
mice. Paradoxically, 
 
Tsk
 
/
 
1
 
 mice have a normal life span
and no evidence of vascular complications (Green et al.,
1975). 
 
Tsk
 
/
 
1
 
 manifestations include all of the following:
thickened skin, bone and cartilage overgrowth, myocardial
hypertrophy, lung emphysema, small tendons with tendon
sheath hyperplasia, and autoimmunity (Green et al., 1975;
Bocchieri and Jimenez, 1990). Homozygous 
 
Tsk
 
 embryos
degenerate in utero at 
 
z
 
8 d of gestation of unknown
 
1
 
Abbreviations used in this paper:
 
 cbEGF, calcium-binding epidermal
growth factor-like; cys, cysteine; 
 
Fbn1
 
, mouse fibrillin 1 gene; MFS,
Marfan syndrome; 
 
Tsk
 
, 
 
Tight
 
 
 
skin
 
 mutation.
Figure 1. Hypothetical models
of fibrillin 1 microfibril assembly
(a) and pathogenesis (b–d). The
pathogenic models are based on
the threshold hypothesis (b) of
Pereira et al. (1999), and on the
studies of the Tsk mutation re-
ported by Kielty et al. (1998) (c)
and described in the present pa-
per (d). 
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causes (Green et al., 1975). A recent study has correlated
the 
 
Tsk
 
/
 
1
 
 phenotype with the segregation of normal and
abnormal fibrillin 1 monomers into two morphologically
distinct groups of beaded polymers through an undefined
assembly process (see Fig. 1 c; Kielty et al., 1998). The au-
thors have argued that the pool of wild-type fibrillin 1 mi-
crofibrils is sufficient to sustain normal vascular develop-
ment of 
 
Tsk
 
/
 
1
 
 animals, whereas the 
 
Tsk
 
 duplication may
cause excessive matrix deposition by altering the binding
of mutant fibrillin 1 microfibrils to growth factors (Kielty
et al., 1998).
Here, we report studies of the 
 
Tsk
 
 mutation using ge-
netic crosses between the various 
 
Fbn1
 
 alleles, cell culture
models, and antibodies specific for the Tsk protein. Our
results exclude the assembly of distinct homotypic fibrillin
1 polymers in 
 
Tsk
 
/
 
1
 
 mice and, instead, suggest the follow-
ing model (see Fig. 1 d). Tsk fibrillin 1 molecules partici-
pate in the initial stage(s) of microfibril assembly but can-
not properly polymerize into long microfibrils unless they
are in the presence of wild-type molecules. Copolymeriza-
tion of Tsk and wild-type fibrillin 1 in 
 
Tsk
 
/
 
1
 
 mice de-
creases the amount of functional microfibrils below the
threshold level of bone overgrowth and lung emphysema,
but not of vascular abnormalities. We also present indirect
evidence suggesting that the 
 
Tsk
 
 duplication destabilizes
the mutant product, thus, rendering the protein more sen-
sitive to proteolysis than the wild-type molecule.
 
Materials and Methods
 
Mice
 
The 
 
Tsk
 
/
 
1
 
 mice used in this study were previously backcrossed onto the
C57BL/6J background (Siracusa et al., 1996). The mg
 
D
 
 and mgR muta-
tions were maintained in the heterozygous state in the mixed C57BL/6J 
 
3
 
129Sv-ter/
 
1
 
 background (Pereira et al., 1997, 1999). Mice were genotyped
by Southern blot hybridization to previously described probes (Siracusa et
al., 1996; Kasturi et al., 1997; Pereira et al., 1997, 1999). Nearly 100 off-
spring were genotyped in each of the compound heterozygote crosses.
 
Cell Cultures
 
Primary dermal fibroblasts were prepared from newborn skin explants of
 
Tsk
 
/
 
1
 
, mgR/
 
1
 
, mg
 
D
 
/
 
1
 
, 
 
Tsk
 
/mg
 
D
 
, 
 
Tsk
 
/mgR, and 
 
1
 
/
 
1
 
 mice, whereas 
 
Tsk
 
/
 
Tsk
 
 cells were prepared from 9-d postcoitum embryos. Mouse fibroblasts
and human amnion, epithelial-like WISH cells (ATCC CCL-25; American
Type Culture Collection) were maintained in DME supplemented with
10% FBS and antibiotics (Gibco Laboratories). Aside from DNA geno-
typing, cell lines were characterized by protein analysis of metabolically
labeled, conditioned medium that was immunoprecipitated and fraction-
ated on SDS-PAGE (see below).
 
Antibodies and Immunoblotting
 
pAb8368 was raised against the peptide M-A-E-Y-Q-A-L-C-S-S-G-P-G-
M-T-S-A-G-T-K synthesized on a Milligen 9050 peptide synthesizer using
standard Fmoc chemistry. The peptide was deprotected, purified by re-
verse-phase chromatography and the amino acid sequence was confirmed
by Edman degradation; the peptide was coupled to keyhole limpet
hemocyanin using the COOH-terminal–added lysine residue, and injected
into a rabbit in the presence of Freund’s adjuvant. Serum was prepared
and tested by ELISA against the immunizing peptide. Antibody specific-
ity was established by Western blot analysis. Conditioned medium of fi-
broblasts cultured 48 h in DME without serum was harvested, briefly cen-
trifuged to clear cell debris, and precipitated with 10% TCA (Sakai and
Keene, 1994). Proteins were separated by 4.5% SDS-PAGE, transferred
onto a nitrocellulose filter and, after treatment with 3% BSA in PBS, the
filter was incubated with the pAb9543 or pAb8368 antibodies and with
phosphatase-conjugated second antibodies. Antibodies were visualized
using nitro-blue tetrazolium (NBT)/5-bromo-4-chloro-3
 
9 
 
indoylphosphate
(BCIP) (Pierce Chemical Co.). Molecular mass markers included myosin
(203 kD), 
 
b
 
-galactosidase (116 kD), and phosphorylase B (87 kD; Bio-
Rad Laboratories). pAb9543 was prepared by immunizing a rabbit with
the recombinant fibrillin 1 polypeptide rF11, which corresponds to the
NH
 
2
 
-terminal half of human fibrillin 1 (Reinhardt et al., 1996). pAb9543
cross-reacts with fibrillin 1 from other species, including mouse, but does
not cross-react with fibrillin 2 (Pereira et al., 1997). Preparation and char-
acterization of mAb201, the antibody that recognizes only human fibrillin
1, have been described previously (Sakai et al., 1986; Reinhardt et al.,
1996).
 
Histological and Ultrastructural Analyses
 
Mouse tissues were processed as previously described (Andrikopoulos
et al., 1995; Pereira et al., 1997, 1999). 6-micron sections were stained with
hematoxylin and eosin, and adjacent sections were assayed for elastic tis-
sue or collagen using a commercial kit (Sigma Chemical Co.). 
 
Tsk
 
/
 
1
 
 and
mgR/mgR mice were 6 mo old, 
 
Tsk
 
/mg
 
D
 
 and 
 
Tsk
 
/mgR mice were 
 
z
 
2 wk
old and were analyzed together with age-matched wild-type littermates.
Samples of adult 
 
Tsk
 
/
 
1
 
 and 
 
1
 
/
 
1
 
 mouse skin were subjected to collage-
nase extraction and molecular sieve chromatography to isolate intact mi-
crofibrils according to the protocol of Kielty et al. (1998). Likewise, con-
fluent cells cultured for 3–4 wk were subjected to the same collagenase
treatment to purify microfibrils from assembled matrix (Kielty et al.,
1998). Samples were prepared and processed for electron microscopy and
immunoelectron microscopy according to the protocols of Sakai and
Keene (1994).
 
Immunoprecipitation and Fibrillin 1 Proteolysis
 
For immunoprecipitation, subconfluent cells were grown for 24 h in Met/
Cys-free DME supplemented with 50 
 
m
 
Ci/ml of [
 
35
 
S]Cys/Met mixture
(ICN Biomedicals; Gayraud et al., 1997; Reinhardt et al., 1997). After col-
lection, the medium was supplemented with protease inhibitors to a final
concentration of 2 mM Pefabloc (Roche Molecular Biochemicals) and
clarified by centrifugation at 2,000 rpm for 5 min. Individual aliquots of 50 
 
m
 
l
of protein G–agarose (Roche Molecular Biochemicals) were incubated
with 3 
 
m
 
l of pAb9543 for 1 h at 4
 
8
 
C. Protein G–antibody complexes were
washed three times with PBS and incubated with 500 
 
m
 
l of 
 
35
 
S-labeled me-
dium for 1 h. The protein G–immune complexes were washed four times
with PBS-Tween 0.05% and twice with PBS and dissociated by boiling for
5 min in SDS-PAGE sample buffer. Immunoprecipitated proteins were
separated in 4.5% SDS-PAGE containing 5% 
 
b
 
-mercaptoethanol. The
same protocol was used for the analysis of fibrillin 1 digestion by plasmin.
To reduce the background, fibronectin was depleted from the radiola-
beled cell culture by gelatin–Sepharose 4B (Amersham Pharmacia Bio-
tech). To isolate fibrillin 1 proteins, 700 
 
m
 
l of protein G was coupled with
150 
 
m
 
l of pAb9543 and the protein G–antibody complex was incubated
overnight at 4
 
8
 
C with 
 
35
 
S-labeled medium (Reinhardt et al., 1997). Im-
Figure 2. Schematic illustration of the wild-type (WT) and mu-
tant (Tsk) fibrillin 1 proteins with the wild-type and mutant se-
quences at the NH2-terminal junction of the Tsk duplication
(gray segment). The sequence of the peptide used to raise the
Tsk-specific antibodies is underlined, and the amino acid change
discussed in the text is highlighted by the asterisk. White rectan-
gles and ovals represent cbEGF and 8-cys motifs, respectively. 
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mune complexes were extensively washed with 50 mM Tris and 0.15 M
NaCl. Fibrillin 1 was eluted with glycine/HCl, pH 2.5, buffered with Tris,
and dialyzed for 12 h against 50 mM Tris, 0.15 M NaCl, and 10 mM CaCl
 
2
 
.
Fractions obtained after elution were counted in a Beckman, LS 5000TD
scintillation counter. Samples containing the same amount of radioactivity
were incubated for 14 h at 37
 
8
 
C with increasing amounts (0–2 
 
m
 
g) of bo-
vine plasmin (Sigma Chemical Co.). Samples were loaded in SDS-PAGE
sample buffer with 5% 
 
b
 
-mercaptoethanol and the degradation products
were separated in 4.5% SDS-PAGE. For autoradiography, gels were fixed
and treated with Amplify (Amersham Pharmacia Biotech) for 20 min, and
then dried before exposure to X-ray film.
 
Indirect Immunofluorescence
 
Early passages of primary culture fibroblasts were plated on glass cover-
slips at a density of 175,000 cell/ml and cultured for 120 h. Cells were
washed with PBS, fixed at –20
 
8
 
C with cold methanol for 20 min and rinsed
with PBS. The primary (pAb9543, pAb8368, or mAb201) and secondary
antibodies (fluorescein isothiocyanate anti-rabbit [Sigma Chemical Co.],
or Cy3 anti-rabbit [Jackson ImmunoResearch Laboratories]) were ap-
plied for 1 h at room temperature (Sakai et al., 1986, 1991). In some exper-
iments, nuclei were counterstained with 0.2 
 
m
 
g/ml propidium iodide. In
the coculture experiments, 75,000 cells/ml from each cell line were plated
onto glass coverslips and cultured for 150 h before being subjected to indi-
rect immunofluorescence. For confocal analysis, cells were cocultured for
2 wk, and the mAb201 antibody was visualized using a secondary anti-
mouse antibody coupled to Texas red (Jackson ImmunoResearch Labora-
tories). Indirect immunofluorescence staining was carried out on 5-
 
m
 
m
cryosections of unfixed skin samples from newborn legs following the
same protocol and by using 3% BSA in PBS for 1 h before staining (Sakai
et al., 1986, 1991). Fluorescence was monitored with a Zeiss Axiophot mi-
croscope using timed exposures at standard magnification and field of
view for a reliable assessment of staining intensity and morphology.
 
Results
Analysis of Compound Heterozygous Mutant Mice
Tsk/1 mice are readily recognizable from wild-type litter-
mates for the tightness of the skin, as early as 5–7 d of age,
and, by 3 mo, they display a characteristic hump in the
shoulder region. Skin tightness correlates with excessive
matrix accumulation and marked hyperplasia in the loose
connective tissue (Fig. 3 a), whereas the hunched posture
is a consequence of bone overgrowth (Green et al., 1975;
Jimenez et al., 1984). Additional distinguishing features of
the Tsk/1 mouse are distended air spaces in the lungs and
enlarged auricles of the heart, both noticeable by the first
month of postnatal life (Green et al., 1975; Martorana et al.,
1989). Bone overgrowth and lung emphysema are also
shared by the mgR/mgR mice, which, however, show no
signs of skin (Fig. 3 b) or myocardial abnormalities
(Pereira et al., 1999). Aneurysmal dilation with focal frag-
mentation of elastic fibers in the aortic wall is the distin-
guishing vascular feature of the mgR/mgR mice, a trait
that becomes more evident between the third and fourth
month of life (Pereira et al., 1999). The phenotypic conse-
quences of the Tsk, mgR, and mgD alleles can be summa-
rized as follows: connective tissue hyperplasia is only asso-
ciated with the Tsk allele; dissecting aneurysm is only
associated with the mgR and mgD alleles; and bone over-
growth and lung emphysema are common traits of the Tsk,
mgR, and mgD alleles (Table I).
Heterozygous fibrillin 1 mutant mice were crossed to ex-
amine the segregation of the distinguishing and common
traits in the compound heterozygous Tsk/mgR and Tsk/
mgD mice. Compound heterozygous Tsk/mgR mice die
within the first 3 wk of life of the same vascular complica-
tions as mgR/mgR animals, which are absent in the paren-
tal Tsk/1 line (Fig. 3, e and f). Moreover, Tsk/mgR ani-
mals exhibit the skin abnormalities of the Tsk/1 mice,
which are absent in mgR/mgR mice (Fig. 3 c). These results
indicate codominant expression of the mutant Tsk and
mgR allele; the same conclusion was reached with com-
pound Tsk/mgD heterozygotes (Table I). Additionally, Tsk/1
animals are more severely affected than mgD/1 mice, in
spite of the fact that the two mutant mice make compara-
ble amounts of wild-type fibrillin 1 (Table I). This last ob-
servation raised the possibility that the Tsk protein may
participate in heterotypic assembly, thus, exerting some
antimorphic effect on the normal gene product.
Microfibrillar Assembly Differs in Tsk/Tsk, Tsk/1, and 
1/1 Cell Cultures
Metabolically labeled polypeptides from the media of cul-
tured fibroblasts with different combinations of Fbn1 al-
leles were immunoprecipitated using polyclonal antibodies
(pAb9543) that recognize the NH2-terminal half of fibril-
lin 1 (Fig. 2). Since pAb9543 epitopes are present in both
wild-type and mutant fibrillin 1 and in both human and
mouse proteins, the pAb9543 antibodies will be referred
to as a-Fbn. As expected, SDS-PAGE analysis of the a-Fbn
immunoprecipitates correlated normal size (350 kD),
shorter (331 kD), and longer (418 kD) fibrillin 1 proteins
with their respective Fbn1 alleles (Fig. 4 a). It also con-
firmed the presence of comparable amounts of mutant and
wild-type fibrillin 1 (418 and 350 kD, respectively) in the
Tsk/1 sample, and the relatively low levels of mgD and
mgR products (331 and 350 kD, respectively) in the com-
pound heterozygous mutant cell cultures (Fig. 4 a).
Next, the a-Fbn antibodies were used to examine the
microfibrillar meshwork assembled in vitro by hypercon-
fluent fibroblasts. Consistent with quantitation of fibrillin
1 expression in Fig. 4 a, the amount of a-Fbn immunofluo-
rescent material deposited after 120 h of culture was no-
ticeably less in mgR/1 than 1/1 cultures (Fig. 5, compare
a and b). A less abundant meshwork was also observed in
the Tsk/1 sample, and even less in the Tsk/mgR cell cul-
tures (Fig. 5, compare c and d). The same relative decrease
in the amount of ordered meshwork was observed with the
mgD/1 and Tsk/mgD cells (data not shown). Taken to-
gether, the results suggested that Tsk fibrillin 1 contributes
poorly to the assembly of the microfibrillar meshwork that
is normally observed in hyperconfluent 1/1 fibroblast cul-
tures. To test this postulate, the analysis was repeated with
an antibody that recognizes only Tsk fibrillin 1.
The Tsk mutation is an in-frame duplication of exons
17–40 and, as a result, the mutant sequence differs from
the normal counterpart by interrupting the continuity of
the second 8-cys motif of fibrillin 1, which is normally en-
coded by exons 16 and 17. In turn, this creates a novel pep-
tide with a single cysteine residue (the segment encoded
by exon 17) immediately adjacent to the 24th cbEGF mo-
tif of fibrillin 1, which is the repeat encoded by exon 40
(Fig. 2; Siracusa et al., 1996). We reasoned that this partial
domain sequence may not be properly folded and would
be a good target for antipeptide antibodies. Accordingly, a
synthetic peptide corresponding to 19 amino acids across
the junction sequence encoded by exons 40/17 was used toGayraud et al. Assembly of Tsk Microfibrils 671
raise anti-Tsk fibrillin 1 antibodies. The specificity of the
resulting antiserum (pAb8368 or a-Tsk) was tested by a
Western blot analysis of proteins from conditioned media
of 1/1,  Tsk/1, and Tsk/Tsk cell cultures. Unlike a-Fbn,
which recognized both the normal 350-kD and mutant
418-kD products, the a-Tsk antiserum showed specificity
only for the longer species (Fig. 4 B). The specificity of
a-Tsk was further supported by the lack of immunostaining
of 1/1 fibroblast cultures (Fig. 6 b). These results indi-
cated that the Tsk peptide sequence is available for anti-
body binding in native Tsk fibrillin 1 and unavailable in
native wild-type fibrillin 1; this, in turn, suggested that the
sequence present in the native wild-type fibrillin 1 is prob-
ably folded in a manner that prevents antibody binding.
Parallel immunostaining of Tsk/1 cell cultures with a-Fbn
and a-Tsk antisera visualized both quantitative and mor-
phological differences. Whereas the a-Fbn antibodies
revealed an elaborate network of immunoreactive mi-
crofibrils,  the  a-Tsk antiserum yielded a reduced amount
of immunoreactive material (Fig. 6, c and d). The same re-
sults were obtained with fibroblasts from the compound
heterozygous Tsk/mgR and Tsk/mgD mutant mice (data
not shown). Surprisingly, both antibodies also revealed an
immunoreactive meshwork in Tsk/Tsk cell cultures (Fig. 6,
Figure 3. Skin and vascular phenotypes of Fbn1 mutant mice. Trichrome-stained skin sections from adult (a and b) and newborn (c and
d) mice heterozygous for the Tsk allele (a), homozygous for the mgR allele (b), compound heterozygous for the Tsk and mgR alleles
(c), and from wild-type (1/1) animals (d). Dermis and epidermis are indicated by the letters D and E, respectively. The arrows point to
the loose connective tissue that contains excessive collagen fibers and is tightly bound to the muscle layer in the adult Tsk/1, and in new-
born Tsk/mgR animals. Cross-section of the ascending aorta stained with van-Gieson from 3-wk-old Tsk/1 (e) and Tsk/mgR (f) mice.
Arrows point to the fragmentation of elastic lamellae in the Tsk/mgR sample, whereas the arrowheads indicate the valve leaflets in the
cross-section of the Tsk/1 vessel. Bars: (a–d) 140 mm; 520 mm (e and f).The Journal of Cell Biology, Volume 150, 2000 672
e and f). However, in this case, the pattern of the immu-
noreactive material was more diffuse, less linear, and more
punctate than the one generated by the a-Fbn antiserum
with 1/1 fibroblasts (Fig. 6 a). The morphological differ-
ences between the wild-type and mutant fibrils were more
apparent when the immunostaining patterns of the 1/1
and Tsk/Tsk cultures were compared at a higher magnifi-
cation (Fig. 6, g and h).
To validate the immunostaining data at the ultrastruc-
tural level, microfibrils were purified from the matrix elab-
orated by hyperconfluent 1/1 and Tsk/Tsk cells and ex-
amined using two distinct electron microscopic techniques,
rotary shadowing, and negative staining (Fig. 7). In Tsk/
Tsk preparations, the former technique visualized mi-
crofibrils that were fewer and significantly shorter than 1/1
microfibrils, and which also display irregular arms and
globular domains (Fig. 7, compare a to c–f). The gentler
technique of negative staining revealed that the shorter
Tsk/Tsk microfibrils have beads of different sizes and ir-
regular periodicity (Fig. 7, compare b to g–k). The immuno-
fluorescence and ultrastructural data suggested the follow-
ing two points. First, Tsk fibrillin 1 molecules by themselves
can initiate polymerization, but are incapable of elaborat-
ing in vitro the same complex meshwork of microfibrils as
wild-type proteins; second, Tsk fibrillin 1 molecules are
partially incorporated into the meshwork assembled by
the wild-type proteins (Fig. 1 d).
Wild-type Fibrillin 1 Drives Partial Polymerization Of 
Mutant Tsk Fibrillin 1
We next tested whether Tsk fibrillin 1 could copolymerize
with wild-type fibrillin 1 by assaying cocultures of normal
and mutant cells. Recently, we found that human amnion,
epithelial-like WISH cells secrete fibrillin 1 proteins into
the medium but fail to assemble a microfibrillar network,
either because the molecules are present at less than opti-
mal concentration or because the cell line lacks other fac-
tors required for fibrillin 1 microfibril assembly. However,
coculturing WISH cells together with mouse dermal fibro-
blasts leads to copolymerization of the human and mouse
fibrillin 1 proteins (Sakai, L.Y., unpublished data). This
same approach was employed here to test whether the mi-
crofibrillar pattern of Tsk/Tsk matrix could be rescued by
wild-type human fibrillin 1 secreted by WISH cells.
WISH and Tsk/Tsk cells were cultured separately or to-
gether, and each sample was immunostained with antibod-
ies specific for human fibrillin 1 (mAb201 or a-hFbn), hu-
man and mouse fibrillin 1 (pAb9543 or a-Fbn), or Tsk
Table I. Genotype-phenotype Correlations in Fbn1 Mutant Mice
Bone
overgrowth
Lung
emphysema
Vascular
dissection
Skin
fibrosis
Myocardial 
hypertrophy
Life
span
Tsk/11 1 2 1 1
Normal
(n 5 100)
mgR/mgR 11 1 2 2 3.8 6 3.4 mo
(n 5 50)
mgD/mgD n.a.* 11 2 2 3 6 1 wk
(n 5 30)
mgD/122 2 2 2 Normal
(n 5 100)
Tsk/mgR n.a.* 11 1 1 16 6 15 d 
(n 5 40)
Tsk/mgD n.a.* 11 1 1
11 6 9 d
(n 5 40)
*This trait is not apparent within the first month of postnatal life.
Figure 4. (a) SDS-PAGE analysis under reducing conditions of
metabolically labeled fibrillin 1 immunoprecipitated with the
pAb9543 antibody from the medium of cultured fibroblasts iso-
lated from wild-type (lane 1), mgR/1 (lane 2), Tsk/1 (lane 3),
Tsk/mgR (lane 4), Tsk/mgD (lane 5) and mgD/mgD (lane 6) adult
mice, and from Tsk/Tsk (lane 7) embryos. (b) Western blot anal-
ysis under native conditions of medium of cell cultures from wild-
type (1/1) and heterozygous (Tsk/1) and homozygous (Tsk/
Tsk) mutant animals with antibodies against the NH2 terminus of
fibrillin 1 (pAb9543 or a-Fbn) and the mutant Tsk  fibrillin 1
(pAb8368 or a-Tsk). In both panels, the molecular weights of the
fibrillin 1 proteins are indicated along with size markers. Con-
taminating traces of fibronectin (Fn) are highlighted in a.Gayraud et al. Assembly of Tsk Microfibrils 673
fibrillin 1 (pAb8368 or a-Tsk). As expected, no extracellu-
lar immunostainable microfibrillar meshwork was ob-
served in the WISH sample with a-hFbn antibodies, and
only diffuse and irregular staining was seen in the Tsk/Tsk
sample using the a-Fbn antiserum (Fig. 8, a and b). Cocul-
turing the two cell types led to the formation of an elabo-
rate meshwork of microfibrillar bundles in which both
a-hFbn and a-Tsk antibodies were colocalized with confo-
cal microscopy (Fig. 8, d–i). Finally, immunoelectron mi-
croscopy of the extracellular microfibrils elaborated by
the cocultured cells confirmed that the immunostainable
meshwork is made of microfibrils containing both human
WISH fibrillin 1 and mouse Tsk fibrillin 1 (Fig. 9, e and f).
The morphology of the rescued Tsk microfibrils displayed
features of the Tsk/Tsk microfibrils, such as abnormal
globular domains and irregular periodicities between glob-
ules; unlike Tsk/Tsk microfibrils, however, these abnormal
structures were embedded within seemingly normal mi-
crofibrils (Fig. 9). Therefore, the results of the coculture ex-
periments demonstrated copolymerization between human
wild-type and mouse mutant fibrillin 1, and suggested that
Tsk monomers participate in the initial steps of fibrillin 1
polymerization. Implicitly, the experiments confirmed that
protein concentration and/or cell type–specific factors con-
tribute to the in vitro assembly of fibrillin 1 microfibrils.
Tsk Fibrillin 1 Is More Susceptible to Proteolysis
Rotary shadowing of microfibrils prepared from Tsk/1
skin has allegedly visualized two morphologically distinct
Figure 5. Immunofluorescence of cultured fibro-
blasts from wild-type (a), mgR/1 (b), Tsk/1 (c)
and Tsk/mgR (d) mice using the anti-fibrillin 1
antibody pAb9543 (a-Fbn). Nuclei were stained
with propidium iodine to appreciate cell density.
Bar, 60 mm.The Journal of Cell Biology, Volume 150, 2000 674
beaded structures in equal amounts (Kielty et al., 1998).
One fraction was reported to exhibit normal morphology
and periodicity, and the other diffuse interbeads and longer
periodicity. We repeated the ultrastructural analysis on Tsk/1
skin samples using the same experimental protocol as Kielty
et al. (1998) and found no evidence for two different popu-
lations of beaded structures (data not shown). Although we
occasionally encountered images of abnormal-beaded struc-
tures of mixed periodicity, their number was too limited to
draw any meaningful conclusion.
Indirect immunofluorescence on Tsk/1 skin with a-Fbn
and a-Tsk antibodies demonstrated that 418-kD fibrillin 1
molecules are integrated into the microfibrillar network.
However, the images also suggested that the junctional
epitopes of Tsk protein may not be as abundant as the
epitopes recognized by a-Fbn, particularly in the mature,
deeper portions of the dermis (Fig. 10). Immunoelectron
microscopy confirmed the presence of mutant fibrillin 1 in
the microfibrils of Tsk/1 skin samples (Fig. 11).
The last experiment was designed to assess the stability
of the Tsk protein using an in vitro assay that compared
the resistance of wild-type and mutant molecules to a
broad substrate protease. To this end, immunoprecipitates
of metabolically labeled fibrillin 1 from cultured Tsk/1
cells were incubated in vitro with increasing amounts of
plasmin. SDS-PAGE analysis of the digested products
documented the more rapid disappearance of the mutant
418-kD product with respect to the wild-type 350-kD spe-
cies (Fig. 12).
Discussion
Our current understanding of the role of fibrillin 1 mi-
crofibrils in connective tissue physiology is based primarily
on the study of human mutations in MFS and homologous
gene targeting in the mouse (Dietz and Pyeritz, 1995;
Ramirez et al., 1999). The dominant inheritance of MFS
has underscored the dominant negative (antimorphic) na-
Figure 6. Immunofluorescence of cultured fibroblasts from wild-type (a and b), Tsk/1 (c and d) and Tsk/Tsk (e and f) animals using the
pAb9543 (a-Fbn) antibody (a, c, and e) or pAb8368 (a-Tsk) antibody (b, d, and f). Bar, 65 mm. Representative fields at a higher magni-
fication of wild-type (g) and Tsk/Tsk (h) samples immunostained with pAb9543 (a-Fbn) are shown to better appreciate morphological
differences, Bar, 15 mm.Gayraud et al. Assembly of Tsk Microfibrils 675
ture of mutations in structural macromolecules, whereas
the MFS-like phenotype of fibrillin 1–deficient (hypomor-
phic) mice has pointed to the importance of optimal levels
of gene expression (Fig. 1 a). Together, these results have
indicated that alternative pathogenic pathways can simi-
larly result in microfibrillar incompetence and pleiotropic
manifestations that include the biomechanical collapse of
the aortic wall (Pereira et al., 1999). These observations
have led to the formulation of the threshold hypothesis,
which correlates decreasing levels of functionally compe-
tent microfibrils with increasing phenotypic diversity and
clinical severity of fibrillin 1 mutations (Pereira et al.,
1999).
According to the pathogenic model of fibrillin 1 muta-
tions in MFS, one would have predicted a full antimorphic
effect of the Tsk mutation leading to the collapse of the
elastic lamellae in the aortic wall and the early demise of
Tsk/1 animals (Dietz and Pyeritz, 1995; Ramirez, 1996).
As this is not the case, an alternative explanation is that
the Tsk gene product may fail to participate in microfibril
assembly and, consequently, that the skeletal and lung ab-
normalities of heterozygous Tsk/1 mice may be indicative
of fibrillin 1 deficiency. In line with this idea, Kielty et al.
(1998) proposed that the longer Tsk fibrillin 1 molecules
polymerize separately from their wild-type counterparts
into beaded microfibrils with extended bead-to-bead peri-
odicities. This conclusion contrasts with the results of the
present study, which offer an alternative explanation for
the metabolic and phenotypic consequences of the Tsk
mutation that is based on three distinct lines of experimen-
tal evidence.
The first line of evidence relies on the phenotypic fea-
tures of mutant mice with different combinations of Fbn1
alleles. Tsk/1 mice produce nearly the same amount of
normal fibrillin 1 as mgD/1 mice and, yet, they are more
severely affected. The most likely explanation for this ap-
Figure 7. Electron microscopy of fibril-
lin 1 microfibrils extracted from the
matrix of 1/1 (a and b) and Tsk/Tsk fi-
broblasts (c–k). Microfibrils were ex-
amined after rotary shadowing (a and
c–f) or after negative staining (b and g–k).
Tsk/Tsk microfibrils were specifically la-
beled with pAb8368 (a-Tsk) antibody
(j and k). Arrowheads in b indicate typ-
ical regular periodicities found be-
tween globular beads in normal mi-
crofibrils. Arrowheads in g indicate
typical irregular periodicities found in
Tsk/Tsk microfibrils. Bar, 100 nm.The Journal of Cell Biology, Volume 150, 2000 676
parent discrepancy is that the greater number of Tsk mole-
cules, compared with mgD products, may exert a partial
antimorphic effect on the wild-type fibrillin 1 proteins. In
this respect, the Tsk allele should be viewed as an antimor-
phic mutation with partial penetrance.
The second line of evidence in support of our patho-
genic model of the Tsk mutation was derived from cell cul-
ture experiments. Immunofluorescence analysis of fibrillin
1 microfibrils elaborated by various cell cultures demon-
strated decreased immunoreactivity in the following order:
1/1, mgR/1 or Tsk/1, and Tsk/mgR. These results indi-
cate that Tsk fibrillin 1 cannot substitute for wild-type
fibrillin 1 in this assembly assay, and imply that the mutant
protein may be assembled into microfibrils more slowly
than the wild-type counterpart. In contrast to the extended
linear microfibrils found in wild-type cultures, immunoflu-
orescence of Tsk/Tsk cultures demonstrated a punctate
pattern of fibrillin 1 in somewhat focal aggregates. Consis-
tent with these images, electron microscopic analyses re-
vealed short strings of beaded fibrils composed of Tsk
fibrillin 1. Compared with wild-type fibrillin 1 microfibrils,
the Tsk/Tsk aggregates exhibited clear irregularities in the
Figure 8. Immunofluorescence of WISH cultures using the mAb201 (a-hFbn) antibody (a), Tsk/Tsk cultures using the pAb9543 (a-Fbn)
antibody (b), and WISH and Tsk/Tsk cocultures using the pAb9543 (a-Fbn) (c), pAb8368 (a-Tsk) (d and g), or mAb201 (a-hFbn) anti-
body (e and h). f and i show the superimposition of the images in d and e and g and h, respectively. The antibody pAb9543 (a-Fbn) was
employed to better appreciate the morphology (b) and extent (c) of the microfibrillar aggregates; additionally, nuclei of cocultured cells
were stained with propidium iodine to document the level of cell confluency. Bars: (a and b) 20 mm; (c) 60 mm; (d–i) 40 mm.Gayraud et al. Assembly of Tsk Microfibrils 677
size and shape of the globular beads, as well as in the dis-
tances between beads. These data strongly suggest that
Tsk fibrillin 1 can polymerize into microfibril-like struc-
tures with abnormal morphologies.
The third and final supporting evidence was based on a
novel coculture assay, which documented the ability of
Tsk fibrillin 1 to interact with the wild-type counterpart.
The resulting fibrillin 1 microfibrils were long and com-
posed of both wild-type human fibrillin 1 and mutant
mouse fibrillin 1, thus, demonstrating that Tsk and wild-
type molecules can copolymerize into a single microfibril
(Fig. 1 d). The microfibrils exhibited focal areas of abnor-
malities similar to those found in Tsk/Tsk fibrils. Interest-
ingly, abnormal microfibrils were not seen in Tsk/1 cell
cultures or tissues. We believe that the reason for this ap-
parent discrepancy reflects intrinsic differences of the two
experimental systems. Fibroblasts synthesize and secrete
the mutant and wild-type products together before they
are assembled extracellularly and a number of factors may
influence this coupled process. In the coculture system, the
two populations of wild-type and mutant molecules are se-
creted separately and, subsequently, are assembled by the
fibroblasts. Therefore, the cocultured system should be
viewed more as a biochemical binding assay to test
homopolymerization versus heteropolymerization rather
than a physiological model of microfibril assembly. With
this reservation in mind, the coculture data indicate that
Tsk fibrillin 1, when copolymerized with wild-type fibrillin
1, can participate in microfibril elongation.
The comparison of the mutant Fbn1 mice has also raised
an interesting structural consideration. The phenotypic se-
verity of Tsk and mgD homozygotes is dramatically differ-
ent. Tsk/Tsk embryos produce a homogenous population
of longer molecules in normal abundance; mgD/mgD mice
produce a homogeneous population of shorter molecules
in a much lower abundance. However, Tsk/Tsk embryos
die in utero at the peri-implantation stage, and mgD/mgD
embryos complete development (Green et al., 1975; Pereira
et al., 1997). Conceivably, these very different outcomes
reflect fundamental differences in the assembly potential
and/or stability of the two mutant chains. Deletion of ex-
ons 19–24 results in no apparent morphological differ-
ences between wild-type fibrillin 1 microfibrils and mgD/
mgD fibrillin 1 microfibrils (Pereira et al., 1997). However,
duplication of this region and surrounding domains in Tsk
fibrillin 1 results in Tsk/Tsk aggregates that display distinct
Figure 9. Electron microscopy of
fibrillin 1 microfibrils extracted from
the matrix of cocultures of WISH and
Tsk/Tsk fibroblasts and viewed after
rotary shadowing (a and b) or after
negative staining (c–f). Arrows in a in-
dicate abnormal globular morpholo-
gies. Arrowheads in d indicate irregu-
larities in periodicity. Microfibrils in e
and f are labeled with mAb201 (recog-
nized by the large, 10-nm, gold conju-
gate), specific for human fibrillin 1, and
pAb8368 (recognized by the small, 5-nm,
gold conjugate), specific for mouse Tsk
fibrillin 1. Bar, 100 nm.The Journal of Cell Biology, Volume 150, 2000 678
abnormalities. The morphological abnormalities of Tsk/
Tsk microfibrils must, therefore, be due to the duplication
of the region encoded by exons 17–40. We propose that
the region containing the long stretch of cbEGF domains,
which is duplicated in Tsk fibrillin 1, is required for proper
linear and unbranched alignment of fibrillin 1 molecules
within the microfibril and for elongation of microfibrils.
The Tsk duplication begins with exon 17, which encodes
the COOH-terminal 18 amino acid residues of the second
8-cys domain (Siracusa et al., 1996). The full 8-cys domain
contains 69 residues, including eight cysteines, which are
predicted to form four intrachain disulfide bonds. Within
the duplicated 18 residues of the 8-cys domain is the final
cysteine residue. Our immunochemical data, using anti-
sera raised to this synthetic peptide, demonstrate that this
sequence is normally folded in the native molecule in a
manner that precludes binding to the antipeptide antibod-
ies. In Tsk fibrillin 1, this region is available for reactivity
to antibodies. We speculate that this improperly folded re-
gion of Tsk fibrillin 1 may result in two effects. It may form
an inappropriate flexible region that could distort the
proper linear alignment of fibrillin 1 necessary for elonga-
tion of microfibrils; and it may cause inappropriate folding
of adjacent domains, leading to a region of increased pro-
teolytic susceptibility. Consistent with the latter predic-
tion, the longer Tsk fibrillin 1 was degraded at a faster rate
than wild-type fibrillin 1 in an in vitro assay of Tsk/1 pro-
teins. It is likely that the duplication of a partial domain se-
quence destabilized adjacent domains, which contain sites
(R or K) for plasmin cleavage. In vivo evidence also sug-
gests that Tsk fibrillin 1 may be selectively degraded by tis-
sue proteases. Immunolocalization of Tsk fibrillin 1 in Tsk/1
skin, which is the result of development over some length
of time, was noticeably reduced compared with antibodies
Figure 10. Immunofluorescence of Tsk/1 skin using the pAb9543 (a-Fbn) (a) or pAb8368 (a-Tsk) antibody (b). The immunofluores-
cence of wild-type skin using the a-Tsk antibody is also shown (c) to appreciate the unspecific nature of the strong epidermis staining of
b. Bar, 60 mm.
Figure 11. Immunoelectron
microscopy of Tsk/1 skin us-
ing the anti-Tsk fibrillin 1 an-
tibody (pAb8368) which lo-
calizes mutant molecules to
elastin associated (A) or iso-
lated (B) microfibrils. Bar,
250 nm.Gayraud et al. Assembly of Tsk Microfibrils 679
directed toward wild-type fibrillin 1. Further supporting this
contention is the notion that the overall amount of matrix
components, including microfibrils, is substantially elevated
in Tsk/1 skin as result of fibrosis (Jimenez et al., 1984). The
most intense labeling by the a-Tsk antibodies was observed
at the dermal-epidermal junction, an area of the skin which
is thought to represent the more immature stroma com-
pared with the connective tissue of the deeper dermis.
In conclusion, we propose that incorporation of Tsk
fibrillin 1 along with wild-type fibrillin 1 renders all mi-
crofibrils more susceptible to proteolysis. According to this
model,  Tsk/1 animals are more severely affected than
mgD/1 mice because of the relatively higher ratio of mutant
to wild-type molecules in the former compared with the lat-
ter. This model is in line with the conclusion of a recent
study on the consequences of mutations in cbEGF domains
in fibrillin 1 (Reinhardt et al., 2000). This study proposed
that proteolysis of conformationally abnormal fibrillin 1
molecules by tissue proteases, which are normally unable to
degrade the microfibrils, may lead to destruction of the su-
pramolecular assembly (Reinhardt et al., 2000). A similar
pathogenic paradigm has recently emerged to explain the
effect of collagen mutations on the long-term stability of the
resulting fibers (Fernandes et al., 1998; Weis et al., 1998).
Although we have provided a reasonable account for the
metabolic and phenotypic consequences of the Tsk muta-
tion, the role of Tsk fibrillin 1 in the genesis of tissue hyper-
plasia and autoimmunity remains unresolved.
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